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httpcense.Abstract Background: Pulmonary embolism (PE) is a frequent and potentially severe disease. So
objective testing is required to establish or exclude the presence of pulmonary embolism.
Aim: This study was carried out to evaluate the diagnostic accuracy of D-dimer test in suspected
pulmonary embolism patients.
Patients and Methods: This study was carried out on 30 patients with clinical and radiological signs
suspicious of PE. All cases were subjected to the following: evaluation of clinical probability byRevised
Geneva Score, plain chest X-ray, CT pulmonary angiography (CTPA), electrocardiographic examina-
tion, arterial blood gases analysis, calculated alveolar arterial oxygen (PA-aO2) gradient, duplex
ultrasonographic, D-dimer assay, and measurement of partial end tidal carbon dioxide (PetCO2).
Results: PE conﬁrmed in 22 cases by CTPA, 20 cases of PE (91%) had positive D-dimer and 2 cases
(9%) had negative D-dimer test. The sensitivity, speciﬁcity and accuracy of D-dimer in diagnosis of PE
were (90%, 37.5%, and 26.6%) respectively. The sensitivity of D-dimer in evaluation of PE when clin-
ical probability of PE low or intermediate was (100%), its speciﬁcity was (37.5%), its negative predic-
tive value (NPV) was (100%) and its positive predictive value (PPV) was (67.7%), while in high clinical
probability its sensitivity was (83.3%), speciﬁcity was (100%) and its PPV was (100%). There was sta-
tistically signiﬁcant difference among the negative and positive PE cases as regards the PetCO2 result
(P< 0.05). The sensitivity of PetCO2 in diagnosis of PE was (68%) its speciﬁcity was (87.5%), NPV
was (50%) and its PPV was (93.7%).
Conclusion: D-dimer alone cannot exclude or conﬁrm the presence of PE. The combination of
D-dimer, PetCO2 628.5 mmHg and the clinical probability could improve diagnostic accuracy in
patients with suspected PE.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Open access under CC BY-NC-ND license.48293330.
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Pulmonary embolism (PE) is a frequent and potentially severe
disease, an accurate and rapid diagnosis of PE remains difﬁcult
in clinical practice because of non-speciﬁc clinical presentation
also treatment carries signiﬁcant potential side effects, so
objective testing is required to establish or exclude the presence
of pulmonary embolism. Although pulmonary angiography is
being considered as the deﬁnitive diagnostic technique or
‘‘gold standard’’ in the diagnosis of acute pulmonary embo-
lism, it suffers from limitation in its use as a result of being rel-
atively expensive, time-consuming and involves radiation and
contrast exposure [1].
In recent years, various combinations of non-invasive aids
to diagnose, including the assessment of clinical probability,
D-dimer testing, end tidal carbon dioxide (PetCO2), venous
compression ultrasonography of the legs (CUS) and ventila-
tion perfusion lung scanning or CT pulmonary angiogram
(CTPA), have been developed and validated to reduce the need
for pulmonary angiography [2].
Pulmonary computed tomography angiography (CTPA)
has become the preferred method to conﬁrm or exclude PE.
It has been shown to have high speciﬁcity, sensitivity, and neg-
ative predictive value for the diagnosis of acute PE [3].
D-dimer is a ﬁbrin degradation product (FDP), a small pro-
tein fragment present in the blood after a blood clot is de-
graded by ﬁbrinolysis. It is so named because it contains two
cross linked D fragments of the ﬁbrinogen protein [4].
D-dimers are not normally present in human blood plasma,
except when the coagulation system has been activated, as in
the presence of thrombosis or disseminated intravascular coag-
ulation. The D-dimer assay depends on the binding of a mono-
clonal antibody to a particular epitope on the D-dimer
fragment. The binding of the antibody is then measured quan-
titatively by one of various laboratory methods [4].
D-dimer assays were characterized by having good sensitiv-
ity and negative predictive value, but poor speciﬁcity because
elevated D-dimer may be present due to various causes as liver
disease, high rheumatoid factor, inﬂammation, malignancy,
trauma, pregnancy, recent surgery as well as advanced age [5].
The aim of this study is to evaluate the diagnostic accuracy of
D-dimer assay in patients with suspected pulmonary embolism.Patients and methods
Patients
This study was performed on 30 patients with clinical suspi-
cion of pulmonary embolism admitted at the Chest Depart-
ment and Respiratory Intensive Care Unit, Zagazig
University Hospitals during the period from January 2010 to
October 2011. There were 18 males and 12 females with mean
age 49.1 ± 10.1 years. Patients were classiﬁed according to ﬁ-
nal diagnosis by CTPA into 22 cases positive for PE (73.3%)
and 8 cases negative for PE (26.7%).
Inclusion criteria
The included patients were suspected to have pulmonary
embolism according to:1. Clinical history and symptoms suggestive of PE [1,2].
2. Clinical examination and signs that raise the suspicion of
PE [1].
Exclusion criteria
Patients were excluded from the study if they: have renal insuf-
ﬁciency, patients refusing to do CTPA and those having hyper-
sensitivity to IV contrast.
Methods
All the studied patients were subjected to the following:
1. Full medical history taking stressing on risk factors and
symptoms suggestive for PE.
2. General and local chest examination for signs of PE and
leg examination for signs of DVT.
3. Evaluation of clinical probability by Revised Geneva
Score:Consisting of calculation of Revised Geneva Score and
categorization of clinical probability of PE as low, inter-
mediate, or high [6].
4. Plain chest X-ray (postero-anterior and lateral views) to
detect radiological ﬁnding suggestive of PE [7].
5. Arterial blood gases analysis.
6. Alveolar–arterial oxygen Gradient:A-aO2 gradient
620 mmHg was considered normal. While A-a gradient
>20 mmHg was considered abnormally wide [8].
7. Electrocardiography (ECG) was used to search for
changes suggestive of PE [9].
8. Routine investigation: Complete blood picture, liver, kid-
ney functions and bleeding proﬁle.
9. D-Dimer assay.
10. Using the ELFA technique (Enzyme Linked Fluorescent
Assay).The assay principle combines a two-step enzyme
immunoassay sandwich method with a ﬁnal ﬂuorescent
detection (ELFA). The D-dimer cut off value
P500 ng/ml was considered positive and results
<500 ng/ml were considered negative [10].
11. Lower limb duplex: Done by a Doppler ultrasound
device (Toshiba sonolayer) with superﬁcial probe
(7.5) MHz, for the diagnosis of DVT according to Pez-
zullo et al. [11].
12. End tidal CO2: Measurement by quantitative capnome-
try (patient monitor, medical industry, model M3, Borg
Ell-Arab) using a nasal cannula. Cut off point was
calculated by the Receiver operating characteristic curve
(ROC curve) which equals 28.5 mmHg. PetCO2 was
considered positive if 628.5 mmHg.
13. Pulmonary CT angiography: Performed for all patients
using (Dual slice Hi speed spiral CTPA). It is the gold
standard for the ﬁnal diagnosis of pulmonary embolism.
Statistical analysis
Data were entered and analyzed using the Microsoft Excel
software. Data were summarized using the arithmetic mean
(X), the standard deviation (SD), chi-square and student t-test.
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ity predictive value, and receiver operating characteristic
(ROC) curve were assessed by medical tests. Signiﬁcant was
detected according to the P value (P< 0.05).
Results
Our study included 30 cases suspected to have PE (18 males
and 12 females). Their age ranged from 25 to 70 years, with
a mean age (49.1 ± 10.1) years. Twenty-two cases (73.3%)
proved to have PE by CTPA and eight cases (26.7%) were neg-
ative. The demographic data and results of diagnostic tests
were used in the study (Table 1). The mean age of positive
and negative PE cases was (49.6 ± 10.8 and 47.7 ± 8.4)
respectively, with statistically non-signiﬁcant difference among
studied cases as regards to age and sex.
Also, hypoxemia and widening of alveolar arterial O2 gradi-
ent were present in 20 cases (91%) with positive PE. While ten
cases had negative PE. (45.5%) hadDVT on duplex ultrasonog-
raphy venous study and 12 cases (54.5%) had normal duplex.
Results of D-dimer test were positive in 20 cases (91%) of
PE and were negative in 2 cases (9%).
Also, measurements of End tidal CO2 showed that 68% of
proved PE had PetCO2 628.5 mmHg and 32% of them had
PetCO2 >28.5 mmHg.
Table 2 shows that the sensitivity of D-dimer test in diagno-
sis of PE was (90%) while its speciﬁcity was (37.5%) as well as
its positive predictive value was (80%) and its negative predic-
tive value was (60%), while sensitivity of PetCO2 in diagnosis
of PE was (68%), its speciﬁcity was (87.5%) and its NPV was
(50%) while its PPV was (93.7%).
Table 3 shows all cases with low clinical probability had
negative D-dimer test and negative PE. 15 cases while interme-
diate clinical probability had positive D-dimer, 10 cases of
them had positive PE and the other 5 cases were negative for
PE, on the other hand all cases with high clinical probability
had PE, 10 cases of them had positive D-dimer and 2 cases
had negative D-dimer result.Table 1 Demographic data and results of diagnostic tests used in t
Parameters Positive for PE (N= 22






No hypoxemia 2 9%
PA-aO2 gradients
>20 mmHg (wide A-aO2 gradient) 20 91%
620 mmHg (normal A-aO2 gradient) 2 9%
Duplex
DVT 10 45.5%
Normal duplex 12 54.5%
D-dimer
Positive (n= 25) 20 91%
Negative (n= 5) 2 9%
PetCO2 (mmHg)
PetCO2 6 28.5 15 68%
PetCO2 > 28.5 7 32%Table 4 shows that the sensitivity, speciﬁcity, NPV and PPV
of D-dimer test in evaluation of pulmonary embolism when the
clinical probability of pulmonary embolism is low or interme-
diate were (100%, 37.5%, 100% and 67.7%), respectively.
While, the sensitivity, speciﬁcity and PPV of D-dimer test in
cases of high clinical probability of PE were (83.3%, 100%
and 100%) respectively.
Table 6 shows that the sensitivity of PetCO2 measurement
in evaluation of PE when the clinical probability of pulmonary
embolism was low or intermediate was (40%), its speciﬁcity
was (87.5%), its NPV was (53.8%) and its PPV was (80%),
while its sensitivity when the clinical probability of PE was
high was (91.6%), speciﬁcity was (100%) as well as its positive
predictive value was (100%).
Discussion
In recent years, various combinations of non-invasive aids to
diagnose PE including the assessment of clinical probability,
D-dimer testing, PetCO2, venous compression ultrasonogra-
phy of the legs (CUS) and ventilation perfusion lung scanning
or CTPA have been developed and validated to reduce the
need for pulmonary angiography [2].
The D-dimer test is usually performed ﬁrst because it can
safely rule out PE and thus, reduce the need for further test-
ing but relying on D-dimer testing alone carries an unaccept-
able risk if the clinical probability of PE is not taken into
account because of its poor speciﬁcity, especially in elderly
patients, patients with cancer, hospitalized patients and preg-
nant women, the D-dimer test excludes PE in only 30% of
patients [12].
So this study was carried out to evaluate the diagnostic
accuracy of D-dimer in suspected pulmonary embolism
patients.
This study included 30 cases suspected to have PE; 22 cases
(73.3%) were positive for PE by CTPA and the other 8 cases
(26.7%) were negative for PE. The mean age of positive and
negative PE cases was (49.6 ± 10.8, 47.7 ± 8.4), respectively.he study.
) Negative for PE (N= 8) P-value



















Table 2 Sensitivity and speciﬁcity of D-dimer test result and
PetCO2 in relation to ﬁnal diagnosis by CTPA.
Sensitivity% Speciﬁcity% NPV% PPV% Accuracy%
D-dimer 90 37.5 60 80 76.6
PetCO2 68 87.5 50 93.7
Table 3 Results of D-dimer test for cases with low, interme-
diate and high clinical probability in relation to ﬁnal diagnosis
by CTPA.
D-dimer test Clinical probability
Low (3) Intermediate (15) High (12)
PE no PE PE no PE PE no PE
Positive (25) 0 0 10 5 10 0
Negative (5) 0 3 0 0 2 0
Table 4 Sensitivity, speciﬁcity, NPV, and PPV of D-dimer
test result in cases with clinical probability in relation to CTPA.
Clinical probability Sensitivity% Speciﬁcity% NPV% PPV%
Low & Intermediate 100 37.5 100 67.7
High 83.3 100 – 100
414 Abdel Rahem I. Youssf et al.These results are in agreement with Stein et al. [5] who
found that the venous thrombo-embolism and pulmonary
embolism are diseases associated with advancing age due to
the cumulative effect of risk factors that patients acquire with
aging such as immobility, trauma, surgery, hypertension and
obesity.
The present study (Table 1) showed that 20 cases (91%) of
the proved PE cases had hypoxemia and (PA-aO2) gradient
>20 mmHg, while 2 cases (9%) had no hypoxemia and (PA-
aO2) gradient 620 mmHg. There was statistically signiﬁcant
difference among the studied cases as regards hypoxemia and
(PA-aO2) gradient (P< 0.05).
These results are in agreement with Adam et al. [1] who
noted that; hypoxemia and wide (A-aO2) gradient are the most
common arterial blood gas abnormalities in patients with PE,
but up to 20% of patients with PE can be normal.
In the current study ten cases (45.5%) of PE had DVT on
duplex ultrasonography venous study and 12 cases (54.5%)
of them had normal duplex. While all cases that were negative
for PE had normal duplex study. There was statistically signif-
icant difference among the negative and positive PE cases as
regards duplex ultrasonographic examination (Table 1).
These results are in agreement with Fawzy [13], who also
proved that; 53. 8% of the patients proved to have PE have
no evidence of acute DVT.
These results are also supported with Adam et al. [1] who
mentioned that DVT is only found in approximately 30% to
50% of patients conﬁrmed to have PE, and a normal ultraso-
nography exam of the leg veins does not rule out PE.
Regarding the ﬁnal diagnosis (Table 1) among 22 cases who
had PE by CTPA 20 cases (91%) had positive D-dimer and 2
cases (9%) had negative D-dimer. On the other hand, 8 cases
were proved to be negative for PE, 5 cases (37.5%) of them
had positive D-dimer and 3 cases (62.5%) had negative D-di-
mer result.
The recorded sensitivity, speciﬁcity, and accuracy of D-
dimer test as regards the ﬁnal diagnosis by CT pulmonary
angiography were 90%, 37.5%, and 76.6% respectively
(Table 2).
This is in accordance to the results of Patrick et al. [14] who
reported that D-dimer assay was unsuitable to be used as a sole
test to exclude or conﬁrm VTE. The recorded sensitivity, spec-
iﬁcity, negative predictive value and positive predictive value
of D-dimer test as regards the ﬁnal diagnosis by CT pulmonary
angiography were (78%, 41%, 84%, and 34%) respectively.
In contrast, Kearon [15], concluded that enzyme-linked
immunosorbent assay (ELISA) D-dimer assays (cut-off of
about 500 ﬁbrinogen-equivalent units/mL) have a sensitivity
for venous thromboembolism of about 98% or higher and
their negative likelihood ratio is high enough to ‘‘rule out’’ pul-
monary embolism in all patients and, consequently, these as-
says can be used as a ‘‘stand-alone’’ test for the exclusion of
pulmonary embolism.The present study (Table 3) showed that all 3 cases with low
clinical probability had negative D-dimer and negative for PE
by CTPA. On the other hand 15 cases with intermediate clin-
ical probability that had positive D-dimer, 10 cases of them
were positive for PE by CTPA while 5 cases were negative
for PE.
Also, it was found that (Table 4) the sensitivity of D-dimer
assay in evaluation of PE when clinical probability of PE was
low or intermediate was (100%), its speciﬁcity was (37.5%),
its NPV was (100%) and its PPV was (67.7%). Also the study
showed that 5 cases with intermediate clinical probability had
false positive D-dimer, this can be explained by the fact that
D-dimer levels are sensitive but non-speciﬁc markers for
thrombosis because Systemic D-dimer values are raised in a
variety of clinical conditions such as; trauma, infection,
malignancy, pregnancy, atrial ﬁbrillation, disseminated intra-
vascular coagulation, acute coronary syndromes and stroke
[16].
Rapid quantitative ELISA assay has been proved to be safe
to exclude PE when the pre-test clinical probability is non high
(low or intermediate) [17].
All cases with high clinical probability were positive for PE
by CTPA. 10 cases of them had positive D-dimer while the
other 2 cases had negative D-dimer (Table 3).
Also the sensitivity of D-dimer assay in evaluation of PE
when the clinical probability was high was (83.3%) while its
speciﬁcity was (100%) as well as its positive predictive value
was (100%) (Table 4).
Florence et al. [2] concluded that D-dimer assay in patients
with high clinical probability was not suggested that clinicians
should ignore a normal D-dimer concentration when the clin-
ical probability is considered to be high [17].
From the previous results it was found that relying on D-di-
mer testing alone carries an unacceptable risk if the clinical
probability of PE is not taken into account so, it is important
to ﬁrst examine the patient and assess the clinical probability,
after which the d-dimer concentration can be taken into ac-
count, in order to prevent physicians from being inﬂuenced by
a normal d-dimer test result when they evaluate the clinical
probability of PE. Patients with a likely clinical probability
Table 5 Characteristics of the 2 patients with a conﬁrmed PE and negative D-dimer.
Age Sex Past history of VTE Risk factors for VTE Clinical probability D-dimer level Duplex CTPA
45 Years Female Past history of PE and DVT Contraceptive pills High 219 +ve +ve
42 Years Male No Thrombophilia (SLE) High 433 ve +ve
Figure 1 CTPA showing right pulmonary artery ﬁlling defect
partially occluding its lumen and left main pulmonary artery ﬁlling
defect occluding its lumen with evidence of bilateral pleural
effusion more evident at left side.
Figure 2 CTPA showing small right and left pulmonary artery
branches ﬁlling defect with left pleural effusion.
Figure 3 Diagonal segments are produced by ties. This curve
shows the cutoff point of PetCO2 among all the study participants
for the prediction of cases of PE from the PetCO2 result.
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outcome [18].
The study showed that; 2 cases with high clinical probabil-
ity had false negative D-dimer as an initial investigation
(Table 5 and Figs. 1 and 2).
The ﬁrst case was a female 45 years old proved to have sys-
temic lupus erythematosus (SLE) as regards to positive anti
nuclear anti bodies (ANA) and anti double strand DNA (Anti
DS). The false negative D-dimer result in this patient was in
agreement with Meesters et al. [19] who noted that the d-dimer
values of patients with SLE may not be signiﬁcantly different
from those of age-matched controls, despite higher levels of
plasma inﬂammatory markers in the blood.
The second case was a female 42 years old had past history
of previous PE and DVT one year ago, already receivedanticoagulant therapy these can be explained by the fact that
the use of agents with predominantly anti-Xa activity as low-
molecular-weight heparin (LMWH) or agents with combined
anti-Xa and antithrombin activity as unfractionated heparin
(UFH), results in equivalent changes in ﬁbrin formation and
degradation after acute thrombosis [4].
These are also in agreement with Patrick et al. [14] who re-
ported drops in mean plasma D-dimer of approximately 40%
within 24 h in heparin-treated patients.
The causes of false negative d-dimer results were small em-
boli, pretreatment with anticoagulant therapy and symptoms
lasting for more than 10 days [18].
In the present study, the optimal cut off point for PetCO2
equal to 28.5 mmHg which was calculated by ROC curve
(Fig. 3).
Regarding the ﬁnal diagnosis (Table 1); among 22 cases who
had PE 15 cases (68%) of them had PetCO2 628.5 and 7 cases
(32%) had PetCO2 >28.5. On the other hand, 8 cases were
proved to be negative for PE, one case (12.5%) had PetCO2
628.5 and 7 cases (87.5%) had PetCO2 >28.5. There was
Table 6 Sensitivity, speciﬁcity, NPV, and PPV of PetCO2
measurement combined with clinical probability.
PetCO2 Sensitivity% Speciﬁcity% NPV% PPV%
Low & Intermediate (18) 40 87.5 53.8 80
High (12) 91.6 100 – 100
Table 7 ROC curve for the prediction of PE from PetCO2
result levels.
Diagnostic test Sensitivity% Speciﬁcity%
Positive PetCO2 level
less than or equal to
cutoﬀ = 28.5 mmHg
87.5 31.8
416 Abdel Rahem I. Youssf et al.statistically signiﬁcant difference among the studied cases as re-
gards PetCO2 result. The PetCO2 sensitivity, speciﬁcity, NPV
and PPV were (68%, 87.5%, 50%, and 93.7%) respectively.
These results are in agreement with those of Kline et al. [20]
who calculated the sensitivity of PetCO2 as 67.2% and speciﬁc-
ity as 76.3%.
In contrast, Hogg et al. [21] recorded the sensitivity of
PetCO2 as 100% but a low speciﬁcity of 22.7%.
The study showed that (Table 6); the sensitivity of PetCO2
in patients with low or intermediate clinical probability for PE
was (40%), its speciﬁcity was (87.5%), its NPV was (53.8%)
and its PPV was (80%).
This result was in agreement with Tadeja et al. [22] who
found that the combination of PetCO2 of more than 28 mmHg
and low clinical probability (PE unlikely) is a potentially safe
method for excluding PE in patients with suspected PE and po-
sitive D-dimer in the pre hospital setting.
The sensitivity of PetCO2 in patients with high clinical
probability for the presence of PE was (91.6%), its speciﬁcity
was (100%), and its PPV was (100%). All cases with high clin-
ical probability had PetCO2 <28.5 mmHg (Table 6).
This result was in agreement with Tadeja et al. [22] who
found that the combination of high clinical probability (PE
likely) and a PetCO2 of less than 28 mmHg had 93.2%
speciﬁcity for the conﬁrmation of PE (Table 7).
This can be explained by the fact that PE signiﬁcantly
decreases alveolar carbon dioxide (CO2) content. It obstructs
blood ﬂow to a normally ventilated area of lung, producing lo-
cally high ventilation, low perfusion relation, therefore increas-
ing alveolar dead space. Gas exhaled from this unperfused
lung unit contains little CO2 and therefore reduces the partial
pressure of end-tidal carbon dioxide (PetCO2) of the whole
lung in relation to the partial pressure of arterial CO2 (PaCO2)
[23].Conclusion
D-dimer alone cannot exclude or conﬁrm the presence of PE.
The combination of D-dimer, PetCO2 628.5 mmHg and the
clinical probability could improve diagnostic accuracy in pa-
tients with suspected PE.Conﬂict of interest statement
None declared.
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